A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could ...

Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential decision reversing a district court’s ...

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

The prosecutor-led program continues her look into juvenile justice. It also continues a state-wide examination of the impact ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...

Grieving parents of children killed by fentanyl pills say the Trump administration has the potential to address the nation's drug epidemic.

Consumer Electronics Show CES the world premier tech show concluded in the US city of Las Vegas on Friday showcasing the latest advanc ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.